Literature DB >> 32527776

Coding-Complete Genome Sequence of a Human Respirovirus 1 Strain from a Clinical Sample in Arizona.

Matthew Scotch1,2, Rolf U Halden3,4,5,6, Anthony Denton7, Helen Sandrolini7, Rafaela S Fontenele8,9, Arvind Varsani8,9.   

Abstract

Human respirovirus 1 is a single-stranded, negative-sense RNA virus in the family Paramyxoviridae Using a high-throughput metagenomic approach, we identified and sequenced the coding-complete genome of a human respirovirus 1 strain from a nasal pharyngeal swab sample from a local health clinic in Tempe, Arizona.
Copyright © 2020 Scotch et al.

Entities:  

Year:  2020        PMID: 32527776      PMCID: PMC7291101          DOI: 10.1128/MRA.00465-20

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Human respirovirus 1 (previously human parainfluenza virus 1) is a single-stranded, negative-sense RNA virus in the family Paramyxoviridae (genus Respirovirus) that causes infections and diseases (e.g., croup) in humans, mainly children (1, 2). The genus Respirovirus includes members with genomes of ∼15,500 nucleotides (nt) long, such as human respirovirus 1, human respirovirus 3, bovine respirovirus 3, caprine respirovirus 3, murine respirovirus, and porcine respirovirus 1 (3). In particular, human respirovirus 1 is not well represented in GenBank (4), with <800 sequence entries to date, only 91 of which are full-length or near-full-length genomes (>12,000 nt). The human respirovirus identified in this study came from an Arizona clinical sample and contains the typical genes found in other respiroviruses, i.e., matrix protein (1,047 nt), nucleocapsid protein (1,575 nt), fusion glycoprotein (1,668 nt), HN glycoprotein (1,743 nt), phosphoprotein (1,803 nt), and RNA-dependent RNA polymerase (6,693 nt). As part of a long-term on-campus influenza surveillance study (5), influenza virus study nasal pharyngeal swab samples from a university health clinic are regularly tested for influenza types A and B, if patients present with influenza-like illness. A sample that tested negative for seasonal influenza types A and B via rapid lateral flow immunoassay (Abbott BinaxNOW) in the health clinic was analyzed using a viral metagenomic approach. One hundred microliters of the buffer from the assay was used to extract viral RNA using the High Pure viral RNA kit (Roche Diagnostics, USA). The resulting RNA was used to prepare a library using the TruSeq stranded total RNA LT sample preparation kit with Ribo-Zero human/mouse/rat (Illumina, USA). The library was sequenced on an Illumina HiSeq X Ten sequencer at Psomagen, Inc. (USA). The raw paired-end (2 × 150-bp) reads (3,496,700 bp) were trimmed using Trimmomatic v0.39 (6) with default settings and de novo assembled using metaSPAdes v3.14.0 (7) with k values of 33, 55, and 77. In the resulting 54,824 contigs, a 15,554-nt contig (GC content, 37%), missing ∼59 nt at the 5′ end and ∼21 nt at the 3′ end, was identified. It shares >81% genomewide pairwise identity with human respiroviruses, as determined using SDT v1.2 (8). A total of 27,066 reads mapped back to the contig with an average depth of coverage of 91×, as determined using BBMap (https://sourceforge.net/projects/bbmap). Open reading frames were identified using ORFfinder (https://www.ncbi.nlm.nih.gov/orffinder). A data set of 92 human respirovirus sequences of >6,500 nt available in GenBank was aligned with the sequence we identified using MUSCLE (9). The resulting alignment was used to infer a maximum likelihood phylogenetic tree using PhyML v3 (10) with GTR+G as the best substitution model selected using jModelTest (11), with 1,000 bootstrap replicates. Three non-wild-type sequences were used as an outgroup. The remaining viruses form two large clades and one smaller monophyletic clade of Wisconsin viruses. Despite a large sampling bias from a study that focused exclusively on Wisconsin (12), the Arizona human respirovirus sequence (GenBank accession number MT232426) clusters with sequences of respiroviruses from New Mexico (KX639498) and California (MK167043), sharing 99.1 to 99.2% genomewide pairwise identity (Fig. 1). Improved sampling across geographic areas is needed to study phylodynamics and the relationship between human respirovirus 1 evolution and geographic spread. In addition, linking clinical phenotype data to genomic epidemiology would allow for a better understanding of the relationship between viral genetics and clinical outcomes.
FIG 1

Maximum likelihood tree, with 1,000 bootstrap replicates, of human respirovirus genomes (n = 93) visualized and annotated using iTOL v4 (13). Branches with less than 60% bootstrap support were collapsed using TreeGraph 2 (14). The locations of sampling are color-coded, and the years of sampling are provided along with taxon names and GenBank accession numbers. The human respirovirus 1 from Arizona (USA) is highlighted in red.

Maximum likelihood tree, with 1,000 bootstrap replicates, of human respirovirus genomes (n = 93) visualized and annotated using iTOL v4 (13). Branches with less than 60% bootstrap support were collapsed using TreeGraph 2 (14). The locations of sampling are color-coded, and the years of sampling are provided along with taxon names and GenBank accession numbers. The human respirovirus 1 from Arizona (USA) is highlighted in red.

Data availability.

Our virus sequence has been deposited in the NCBI databases SRA, under the accession number SRR11676238, and GenBank, under the accession number MT232426.
  12 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  jModelTest 2: more models, new heuristics and parallel computing.

Authors:  Diego Darriba; Guillermo L Taboada; Ramón Doallo; David Posada
Journal:  Nat Methods       Date:  2012-07-30       Impact factor: 28.547

3.  GenBank.

Authors:  Eric W Sayers; Mark Cavanaugh; Karen Clark; James Ostell; Kim D Pruitt; Ilene Karsch-Mizrachi
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

4.  Genome sequencing and phylogenetic analysis of 39 human parainfluenza virus type 1 strains isolated from 1997-2010.

Authors:  Eric T Beck; Jie He; Martha I Nelson; Michael E Bose; Jiang Fan; Swati Kumar; Kelly J Henrickson
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

5.  SDT: a virus classification tool based on pairwise sequence alignment and identity calculation.

Authors:  Brejnev Muhizi Muhire; Arvind Varsani; Darren Patrick Martin
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

6.  Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands.

Authors:  My V T Phan; Georgina Arron; Corine H GeurtsvanKessel; Robin C Huisman; Richard Molenkamp; Marion P G Koopmans; Matthew Cotten
Journal:  Microbiol Resour Announc       Date:  2019-04-11

7.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments.

Authors:  Ivica Letunic; Peer Bork
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

8.  Two Cases of Primary Human Parainfluenza Virus 1 Pneumonia in Which Bronchoalveolar Lavage Fluid Yielded Human Parainfluenza Virus 1.

Authors:  Takashi Ishiguro; Yasuhito Kobayashi; Kenji Takano; Ryota Ozawa; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Intern Med       Date:  2019-09-11       Impact factor: 1.271

9.  TreeGraph 2: combining and visualizing evidence from different phylogenetic analyses.

Authors:  Ben C Stöver; Kai F Müller
Journal:  BMC Bioinformatics       Date:  2010-01-05       Impact factor: 3.169

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.